Structural and biochemical characterization of Schlafen11 N-terminal domain

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research..

Schlafen11 (SLFN11) is one of the most studied Schlafen proteins that plays vital roles in cancer therapy and virus-host interactions. Herein, we determined the crystal structure of the Sus scrofa SLFN11 N-terminal domain (NTD) to 2.69 Å resolution. sSLFN11-NTD is a pincer-shaped molecule that shares an overall fold with other SLFN-NTDs but exhibits distinct biochemical characteristics. sSLFN11-NTD is a potent RNase cleaving type I and II tRNAs and rRNAs, and with preference to type II tRNAs. Consistent with the codon usage-based translation suppression activity of SLFN11, sSLFN11-NTD cleaves synonymous serine and leucine tRNAs with different efficiencies in vitro. Mutational analysis revealed key determinates of sSLFN11-NTD nucleolytic activity, including the Connection-loop, active site, and key residues essential for substrate recognition, among which E42 constrains sSLFN11-NTD RNase activity, and all nonconservative mutations of E42 stimulated RNase activities. sSLFN11 inhibited the translation of proteins with a low codon adaptation index in cells, which mainly dependent on the RNase activity of the NTD because E42A enhanced the inhibitory effect, but E209A abolished inhibition. Our findings provide structural characterization of an important SLFN11 protein and expand our understanding of the Schlafen family.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:51

Enthalten in:

Nucleic acids research - 51(2023), 13 vom: 21. Juli, Seite 7053-7070

Sprache:

Englisch

Beteiligte Personen:

Hou, Pengjiao [VerfasserIn]
Hao, Wei [VerfasserIn]
Qin, Bo [VerfasserIn]
Li, Mengyun [VerfasserIn]
Zhao, Rong [VerfasserIn]
Cui, Sheng [VerfasserIn]

Links:

Volltext

Themen:

9014-25-9
EC 3.1.-
Journal Article
Nuclear Proteins
RNA, Transfer
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Ribonucleases

Anmerkungen:

Date Completed 26.07.2023

Date Revised 04.03.2024

published: Print

Citation Status MEDLINE

doi:

10.1093/nar/gkad509

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM357957555